Diagnostic Imaging Devices are used for the visualization of structural and functional patterns of organs or tissues. X-ray systems use high-energy radiation to diagnose diseases by taking images of internal structures of body. GlobalData uses proprietary data and analytics to provide a comprehensive report on the x-ray systems devices market, including market shares of different players within New Zealand. Buy the latest report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights Israel Robotic Surgical Systems Market Share

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

In 2023, GlobalData’s Market Model methodology determined that the leading player in the x-ray systems market in New Zealand was Siemens Healthineers followed by GE Healthcare Technologies, Philips Healthcare Informatics, Canon Medical Systems, Shimadzu, Fujifilm and Carestream Health.

Analog X-ray systems, Digital X-ray systems and Retrofit X-ray systems are the different types of X-ray systems. Tracked here are the equipment only and not accessories which are sold separately. Digital X-ray systems such as Computed Radiography (CR) X-ray Systems and Direct Digital Radiography (DDR) X-ray Systems are tracked under this category. CR involves an indirect imaging system. DDR is a form of X-ray imaging, where digital X-ray sensors are used instead of traditional photographic film.

The value of the x-ray systems devices market within New Zealand was expected to be over $4m in 2023.

For the latest complete market share analysis of x-ray systems device market in New Zealand, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.